These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 22970010)
1. Continuous administration of recombinant human endostatin (Endostar): A pre-clinical safety study. Huang R; Zhan Q; Zhou X; Chu Z; Jiang J; Liang X Exp Ther Med; 2012 Jun; 3(6):1018-1022. PubMed ID: 22970010 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice. Ma X; Yao Y; Yuan D; Liu H; Wang S; Zhou C; Song Y PLoS One; 2012; 7(12):e53449. PubMed ID: 23285296 [TBL] [Abstract][Full Text] [Related]
3. Human recombinant endostatin Endostar attenuates hepatic sinusoidal endothelial cell capillarization in CCl4‑induced fibrosis in mice. You Q; Kong LJ; Li FD; Wang HY; Liu DG; Pei FH; Song JT; Xu J; Chen J Mol Med Rep; 2015 Oct; 12(4):5594-600. PubMed ID: 26239504 [TBL] [Abstract][Full Text] [Related]
4. Different administration routes of recombinant human endostatin combined with concurrent chemoradiotherapy might lead to different efficacy and safety profile in unresectable stage III non-small cell lung cancer: Updated follow-up results from two phase II trials. Honglian M; Zhouguang H; Fang P; Lujun Z; Dongming L; Yujin X; Yong B; Liming X; Yirui Z; Xiao H; Jin W; Yue K; Lvhua W; Ming C Thorac Cancer; 2020 Apr; 11(4):898-906. PubMed ID: 32068962 [TBL] [Abstract][Full Text] [Related]
5. [Therapeutic features of endostar, a modified endostatin, on ascites tumor in mice]. Wei HM; Qin SK; Yin XJ; Chen YL Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1509-13. PubMed ID: 20650753 [TBL] [Abstract][Full Text] [Related]
6. Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer. Wang R; Qin S; Chen Y; Li Y; Chen C; Wang Z; Zheng R; Wu Q Oncol Rep; 2012 Aug; 28(2):439-45. PubMed ID: 22641525 [TBL] [Abstract][Full Text] [Related]
7. Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells. Ling Y; Yang Y; Lu N; You QD; Wang S; Gao Y; Chen Y; Guo QL Biochem Biophys Res Commun; 2007 Sep; 361(1):79-84. PubMed ID: 17644065 [TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of Endostar(rh-endostatin) combined with gemcitabine in different administration sequences to treat Lewis lung carcinoma. Li Y; Huang P; Peng H; Yue H; Wu M; Liu S; Qin R; Fan J; Han Y Cancer Manag Res; 2019; 11():3469-3479. PubMed ID: 31114380 [No Abstract] [Full Text] [Related]
9. Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts. Jing Y; Xiu-Juan Z; Hong-Jiao C; Zhi-Kui C; Qing-Fu Q; En-Sheng X; Li-Wu L J Cancer Res Clin Oncol; 2019 May; 145(5):1191-1200. PubMed ID: 30805775 [TBL] [Abstract][Full Text] [Related]
10. Recombinant human endostatin, Endostar, enhances the effects of chemo-radiotherapy in a mouse cervical cancer xenograft model. Jia Y; Liu M; Cao L; Zhao X; Wu J; Lu F; Li Y; He Y; Ren S; Ju Y; Wang Y; Li Z Eur J Gynaecol Oncol; 2011; 32(3):316-24. PubMed ID: 21797125 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of recombinant human endostatin and docetaxel on human umbilical vein endothelial cells in different growth states. Xu WJ; Huang C; Wang J; Jiang RC; Wang LC; Lin L; Liu ZJ; Sun BC; Li K Chin Med J (Engl); 2011 Sep; 124(18):2883-9. PubMed ID: 22040497 [TBL] [Abstract][Full Text] [Related]
12. Effects of Combined Simultaneous and Sequential Endostar and Cisplatin Treatment in a Mice Model of Gastric Cancer Peritoneal Metastases. Jia L; Ren S; Li T; Wu J; Zhou X; Zhang Y; Wu J; Liu W Gastroenterol Res Pract; 2017; 2017():2920384. PubMed ID: 28197204 [No Abstract] [Full Text] [Related]
13. Antitumor effect of recombinant human endostatin combined with cisplatin on rats with transplanted Lewis lung cancer. Yu ZW; Ju YH; Yang CL; Yu HB; Luo Q; Ma YG; Liu YY Asian Pac J Trop Med; 2015 Aug; 8(8):664-7. PubMed ID: 26321522 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models. Zhou J; Wang L; Xu X; Tu Y; Qin S; Yin Y Oncol Lett; 2012 Nov; 4(5):976-980. PubMed ID: 23162635 [TBL] [Abstract][Full Text] [Related]
15. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Kisker O; Becker CM; Prox D; Fannon M; D'Amato R; Flynn E; Fogler WE; Sim BK; Allred EN; Pirie-Shepherd SR; Folkman J Cancer Res; 2001 Oct; 61(20):7669-74. PubMed ID: 11606410 [TBL] [Abstract][Full Text] [Related]
16. The inhibitory effects of rh-endostatin (YH-16) in combination with radiotherapy on lung adenocarcinoma A549 in mice and the underlying mechanisms. Wu H; Deng J; Yu S; Wang X; Chen Y J Huazhong Univ Sci Technolog Med Sci; 2010 Feb; 30(1):108-12. PubMed ID: 20155466 [TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of different administration sequences of cisplatin and Endostar on Lewis lung carcinoma. Fan J; DU J; Wu J; Fu S; Hu D; Wan Q Oncol Lett; 2015 Feb; 9(2):822-828. PubMed ID: 25624906 [TBL] [Abstract][Full Text] [Related]
18. Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models. Peng F; Xu Z; Wang J; Chen Y; Li Q; Zuo Y; Chen J; Hu X; Zhou Q; Wang Y; Ma H; Bao Y; Chen M PLoS One; 2012; 7(4):e34646. PubMed ID: 22496834 [TBL] [Abstract][Full Text] [Related]
19. Endostar, a novel human recombinant endostatin, attenuates liver fibrosis in CCl4-induced mice. Chen J; Liu DG; Yang G; Kong LJ; Du YJ; Wang HY; Li FD; Pei FH; Song JT; Fan YJ; Liu AY; Wang XH; Li BX Exp Biol Med (Maywood); 2014 Aug; 239(8):998-1006. PubMed ID: 24872431 [TBL] [Abstract][Full Text] [Related]
20. Endostar continuous versus intermittent intravenous infusion combined with chemotherapy for advanced NSCLC: a systematic review and meta-analysis including non-randomized studies. Wang B; Xu L; Li Q; Man S; Jin C; Liu L; Zhan S; Ning Y BMC Cancer; 2020 Oct; 20(1):1021. PubMed ID: 33087103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]